Environmental Health & Safety

University of Colorado Boulder

Resources

Template for Reporting Incidents Involving Recombinant DNA to the NIH Office of Biotechnology Activities (OBA)

General Description

The NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) states that “…any significant problems, violations of the NIH Guidelines, or any significant research-related accidents and illnesses” must be reported to NIH OBA within 30 days. Certain types of incidents must be reported on a more expedited basis. Spills or accidents in BL2 laboratories resulting in an overt exposure must be immediately reported to NIH OBA. Spills or accidents occurring in high containment (BL3 or BL4) laboratories resulting in an overt or potential exposure must be immediately reported to NIH OBA.

This template is intended to facilitate the reporting of incidents that occur during the conduct of research subject to the NIH Guidelines. You may download this template as a Word document and the fields will expand according to the amount of text entered.  Use of this template is not required and other formats may be acceptable.

A separate template for reporting Human Gene Transfer Adverse Events is available at: http://www4.od.nih.gov/oba/RAC/Adverse_Event_Template.doc

Please note that submitting this completed template to NIH OBA does NOT fulfill the reporting requirements of other agencies.  You should verify with the other parties to whom you must report whether the use of this template is acceptable.